Published on 23 Oct 2024 on Benzinga · via Yahoo Finance
FDA Approves Pfizer's Respiratory Syncytial Virus Vaccine Abrysvo For Adults...
On Tuesday, the FDA approved Pfizer Inc’s (NYSE:PFE) Abrysvo (Respiratory Syncytial Virus Vaccine),...
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free